Dr. Wapnir Receives Smart Foundation Funding for Breast Cancer Research
January 13, 2025
Dr. Irene Wapnir has received funding from the Smart Foundation for her research project: “Early and Late Hormone-positive Ipsilateral Breast Tumor Recurrences’ Genomic Signatures.”
“Our study focuses on trying to characterize the types of tumors that recur locally after lumpectomy or breast conserving surgery,” said Wapnir. “Some of these recurrences appear decades later, so we wonder: are these new cancers that develop or cancer cells that remained dormant in the area and survived all the prior treatments?”
About half of these recurrences are highly-associated with the presence of metastasis in tissues and organs outside the breast. Genomic signatures have defined sub-groups of tumors with aggressive and less aggressive behaviors.
“One of the goals of our research is to correlate these signatures to early or late recurrences. In fact, we might use the findings to classify an in-breast recurrence as early or late,” said Wapnir.
Wapnir will be working closely with Dr. Colin Bergstrom, one of the fellows in the Breast Program who has worked with Dr. Jennifer Caswell and Dr. Christina Curtis on these genomic signatures.
Much of Wapnir’s national clinical trials work has been on studying the longterm outcomes of patient in NSABP trials who experienced locoregional recurrences. She was also chair of Chemotherapy as Adjuvant for Locally Recurrent breast cancer (CALOR) trial, which investigated the effectiveness of chemotherapy after local therapy for isolated locoregional recurrence.
Additionally, the Williams Foundation is continuing to support Dr. Wapnir’s project: Investigator Initiated Randomized Trial of Neoadjuvant partial breast radiation therapy for ductal carcinoma in situ (DCIS).
Media Contact
Bio
About Stanford Surgery
The Stanford University Department of Surgery is dedicated to inventing the future of surgical care through:
• pioneering cutting-edge research,
• developing the next generation of leaders, and
• healing through incomparable surgical skills and compassion.
To learn more, please visit surgery.stanford.edu
The Latest
SurgeryStanford Surgery Announces New Chief of Plastic Surgery
Dr. Arash Momeni will succeed Dr. Jim Chang as Chief of Stanford's Division of Plastic and Reconstructive Surgery, effective September 1, 2026.
Division of Plastic & Reconstructive SurgeryINSIDE CSPS 2026: Stanford Plastic Surgery Recap
The 2026 California Society of Plastic Surgeons (CSPS) Annual Meeting was held in Huntington Beach, CA from April 9-12, 2026. Stanford Plastic Surgery had a strong presence throughout the meeting—from the podium to panel discussions and award recognition.
CAP ProfilesDr. Simeng Wang Promoted!
Dr. Simeng Wang has been promoted to the rank of Clinical Assistant Professor, effective September 1, 2026. Dr. Wang has been a Clinical Instructor in the Division of General Surgery, specializing in Critical Care.
SurgeryInnovation Council Announces 2026 Seed Grant Winner
Dr. Aussama Nassar is this year's Innovation Seed Grant awardee.
SurgerySpotlight: Dr. Michael Mwachiro, Kovitz Visiting Professor
On February 24th, 2026 the Department of Surgery welcomed Dr. Michael Mwachiro as the Kovitz Visiting Professor. Dr. Mwachiro is the President of the Surgical Society of Kenya and Chair of the Education and Research committee for the College of Surgeons of East, Central and Southern Africa (COSECSA). Prior to and following his lecture, he joined the department for a two-week observership with a special emphasis on Stanford’s advanced endoscopy program.
Daniel Ahn, MD, BS, discusses the need for pediatric heart transplant policy reformDaniel Ahn, MD, BS, discusses the need for pediatric heart transplant policy reform | Contemporary Pediatrics
Stanford General Surgery Resident Daniel Jaechul Ahn, MD, BS, explains how status exceptions are used to navigate the current 3-status system and why policy reform is necessary.
SurgeryA Deep Dive into HIPEC and PIPAC with Dr. Byrne Lee
In this episode of Scrubcast, host Rachel Baker speaks with Dr. Byrne Lee, a surgical oncology expert at Stanford University, about innovative cancer treatments like HIPEC and PIPAC, while exploring the personal motivations and collaborative approaches that drive advancements in patient care. Dr. Lee shares his personal connection to cancer and emphasizes the importance of a patient-centered approach in navigating the complexities of treatment.
Vascular & Endovascular SurgeryDr. Nazish Sayed Receives NIH-NHLBI R35 Emerging Investigator Award
Dr. Nazish Sayed, MD, PhD, Associate Professor in the Division of Vascular Surgery and a faculty member of the Stanford Cardiovascular Institute, has been awarded the National Institutes of Health–National Heart, Lung, and Blood Institute (NIH-NHLBI) Emerging Investigator Award (R35).
Division of Plastic & Reconstructive SurgeryDr. James Chang Receives 2026 David P. Green Mentorship Award
The American Society for Surgery of the Hand has announced that James Chang, MD, Professor of Plastic & Reconstructive Surgery at Stanford University, has been selected as the recipient of the 2026 David P. Green Mentorship Award.
Vascular & Endovascular SurgeryDr. Chikage Noishiki Receives American Heart Association Career Development Award
Dr. Chikage Noishiki, an Instructor in the Sayed Lab within the Division of Vascular Surgery, Department of Surgery, has been awarded an American Heart Association (AHA) Career Development Award.